What is the appropriate management for acute tonsillitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Acute Tonsillitis

For acute tonsillitis, use clinical scoring systems (Centor/McIsaac) to identify bacterial cases requiring antibiotics, prescribe penicillin V or amoxicillin for 10 days when Group A Streptococcus is confirmed, and provide symptomatic relief with analgesics—most cases are viral and require only supportive care. 1

Diagnostic Approach

Clinical Assessment

  • Apply the Centor or McIsaac scoring system to estimate the probability of Group A Streptococcal (GAS) infection 1, 2
  • A score ≥3 warrants further testing with rapid antigen detection test (RADT) or throat culture 2, 3
  • Do not rely on exudate alone—exudative tonsillitis in children does not reliably indicate streptococcal etiology 3

Laboratory Testing

  • Perform pharyngeal swab with RADT or culture only when clinical score is ≥3 1, 2
  • Routine blood tests (CBC, CRP, procalcitonin) are not indicated for uncomplicated acute tonsillitis and do not change management 2, 3
  • Do not measure antistreptolysin O (ASLO) titers—they have no value in acute tonsillitis diagnosis 2

Antibiotic Therapy (When Indicated)

First-Line Treatment for Confirmed GAS

Penicillin V remains the antibiotic of choice for GAS pharyngitis 1, 2:

  • Children: 250 mg twice or three times daily for 10 days 1
  • Adolescents/Adults: 250 mg four times daily or 500 mg twice daily for 10 days 1
  • Alternative: Amoxicillin 50 mg/kg once daily (max 1000 mg) or 25 mg/kg twice daily (max 500 mg/dose) for 10 days 1
  • Intramuscular option: Benzathine penicillin G as single dose (<27 kg: 600,000 U; ≥27 kg: 1,200,000 U) 1

Penicillin Allergy Alternatives

  • First-generation cephalosporins (avoid in immediate-type hypersensitivity): Cephalexin 20 mg/kg/dose twice daily (max 500 mg/dose) for 10 days 1
  • Clindamycin: 7 mg/kg/dose three times daily (max 300 mg/dose) for 10 days 1
  • Macrolides (note geographic resistance): Azithromycin 12 mg/kg once daily (max 500 mg) for 5 days or clarithromycin 7.5 mg/kg/dose twice daily (max 250 mg/dose) for 10 days 1

Treatment Duration

The full 10-day course is essential—a 7-day penicillin regimen was superior to 3 days in resolving symptoms 1, and 10-day courses reduce recurrence risk 4

When NOT to Prescribe Antibiotics

  • Most tonsillitis is viral and requires only supportive care 5
  • Low-risk patients (Centor/McIsaac score <3) should not receive antibiotics for prevention of rheumatic fever or glomerulonephritis 3
  • Prevention of suppurative complications (peritonsillar abscess, otitis media, lymphadenitis) is not a specific indication for antibiotics in most patients 3
  • Consider delayed antibiotic prescription strategy—monitor for 2-3 days in ambiguous cases, which is highly effective and reduces antibiotic use 3

Symptomatic Management

Analgesia

  • Paracetamol (acetaminophen) and NSAIDs are effective for pain relief 1, 6
  • Use codeine with caution in pediatric patients 6
  • Topical anesthetics (lozenges, sprays with benzocaine, lidocaine) may provide temporary relief but represent choking hazard in young children 1

Corticosteroids

Moderate evidence supports single-dose corticosteroid administration for symptom relief, followed by reassessment 6. However, the IDSA guideline does not recommend routine corticosteroid use given the self-limited nature of GAS pharyngitis, efficacy of analgesics, and potential adverse effects 1

Supportive Care

  • Hydration 5
  • Warm salt water gargles (though not formally studied) 1

Follow-Up and Carrier State

Post-Treatment Testing

  • Do not perform routine post-therapy testing (throat culture, blood tests, urinalysis, ECG, or ASLO titers) after successful treatment 1, 2
  • Only retest patients with recurrent symptoms within weeks to months 1

GAS Carriers

  • Chronic pharyngeal carriers do not require identification or treatment—they are unlikely to spread infection or develop complications 1
  • Up to 20% of asymptomatic school-age children may be GAS carriers during winter/spring 1
  • Consider carrier state in patients with repeated positive tests and viral symptoms 1

Surgical Considerations

Tonsillectomy is NOT recommended solely to reduce frequency of GAS pharyngitis 1. However, tonsillectomy is indicated for recurrent acute tonsillitis meeting Paradise criteria: ≥7 adequately treated episodes in the preceding year, ≥5 episodes in each of the preceding 2 years, or ≥3 episodes in each of the preceding 3 years 4. Recent evidence shows tonsillectomy reduces sore throat days by approximately 47% compared to conservative management in adults with recurrent tonsillitis 7.

Key Clinical Pitfalls

  • Avoid antibiotic overuse: Most tonsillitis is viral; use scoring systems and confirmatory testing 1, 3
  • Complete the full 10-day antibiotic course when prescribed to prevent recurrence 4
  • Do not use macrolides as first-line therapy—resistance varies geographically and temporally 1, 2
  • Avoid unnecessary testing: No routine blood work, ASLO titers, or post-treatment cultures 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Clinical practice guideline: tonsillitis I. Diagnostics and nonsurgical management.

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2016

Research

Tonsillitis.

Primary care, 2025

Research

Controversies in the management of acute tonsillitis: an evidence-based review.

Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.